Prostate cancer immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prostate cancer immunotherapy

Published:2022-01-16 Issue:5 Volume:22 Page:577-590
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Mitsogiannis Iraklis¹,Tzelves Lazaros¹,Dellis Athanasios¹²,Issa Hussein³,Papatsoris Athanasios¹,Moussa Mohammad³

Affiliation:

1. 2nd Department of Urology, School of Medicine, Sismanoglio Hospital, National and Kapodistrian University of Athens, Athens, Greece

2. Department of Surgery, School of Medicine, Aretaieion Hospital, National and Kapodistrian University of Athens, Athens, Greece

3. Department of Urology, Al Zahraa Hospital, University Medical Center, Lebanese University, Beirut, Lebanon

Funder

is not funded

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2022.2027904

Reference102 articles.

1. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

2. A pharmacoeconomic evaluation of pharmaceutical treatment options for prostate cancer

3. Prevalence of Prostate Cancer Clinical States and Mortality in the United States: Estimates Using a Dynamic Progression Model

4. Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

5. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CircBIRC6 affects prostate cancer progression by regulating miR-574-5p and DNAJB1;Cancer Biology & Therapy;2024-09-11

2. A tumour‐associated macrophage‐based signature for deciphering prognosis and immunotherapy response in prostate cancer;IET Systems Biology;2024-08-13

3. Advancements in nanomedicine: Precision delivery strategies for male pelvic malignancies – Spotlight on prostate and colorectal cancer;Experimental and Molecular Pathology;2024-06

4. Metastatic castration-resistant prostate cancer and immune checkpoint inhibitors;Cancer Urology;2024-05-17

5. Comprehensive pan-cancer analysis reveals SIRT5 is a predictive biomarker for prognosis and immunotherapy response;Functional & Integrative Genomics;2024-03-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3